drugset / Trial / NCT01114698
A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive Disorder
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the effectiveness and safety of JNJ26489112 compared with an active control (Venlafaxine XR) and placebo in patients with Treatment-Resistant Major Depressive Disorder.
Timeline
- Start
- 2011-03
- Primary completion
- 2012-01
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ26489112 | Small molecule | 1000 mg | Oral |
| Comparator | Venlafaxine | Small molecule | 150 mg | Oral |